X

Chemo-Pharma Laboratories Ltd Stock Analysis

Small Cap
Evaluated by 53 users | BSE: 506365 | NSE: |
Trading
Chemo Pharma Laboratories has been an established company since 1942 and has been making pharmaceuticals and also had diversified into bulk drugs. However, due to increase in competition and flow of new drugs, the company had to dispose the business and pay all its liabilities and dues....

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed 0.09%2.7%3.08%4.98%5.48%4.05%14.61%1%2.02%4.03%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 0000000000
Y-o-Y Gr. Rt.-NANANANANANANANANA
Adjusted EPS (Rs.) 0.020.790.951.611.871.457.60.671.382.83
Y-o-Y Gr. Rt.-3850%20.3%69.5%16.2%-22.5%424.1%-91.2%106%105.1%
Book Value per Share (Rs.) 24.1229.7730.7332.3434.1435.5966.8267.4968.8671.63
Adjusted Net Profit 00.10.10.20.30.21.10.10.20.4
Net Op. Cash Flow (Rs. Cr.) 0.4-1.5-0.4-0.2-0.1-0.46.4-1.7-5.54.8
Debt to Cash Flow from Ops 1.29-0.08-0.3-0.72-2.34-0.280.02000
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Chemo-Pharma Laboratories Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales NANANANA
Adjusted EPS 73.4%8.6%-28.1%105.1%
Book Value per Share 12.9162.34
Share Price -1.3% -1.4% -19.9% 179.7%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) 0.12.923.165.15.614.1514.8412.024.03
Operating Profit Margin (%) 0000000000
Net Profit Margin (%) 0000000000
Debt to Equity 0.150.030.030.020.020.020.01000
Working Capital Days 0000000000
Cash Conversion Cycle 0000000000
Entity Percentage Holding
Promoters 27.89%
Institutions 0.53%
Non-Institutions 71.59%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Chemo-Pharma Laboratories Ltd's performance infers:

Chemo-Pharma Laboratories Ltd earnings have grown by 8.6%, whereas share price has depreciated -1.4% CAGR over the past five years, indicating the company's share price is likely undervalued. However, for specific investment actions please connect with your investment advisor.

Data is not available for this company

Chemo Pharma Laboratories has been an established company since 1942 and has been making pharmaceuticals and also had diversified into bulk drugs. However, due to increase in competition and flow of new drugs, the company had to dispose the business and pay all its liabilities and dues.

Presently the company has its own cash resource, with this the company is proposing to diversify and to take over sick company which has excellent future potential. The company

Chemo Pharma Laboratories has been an established company since 1942 and has been making pharmaceuticals and also had diversified into bulk drugs. However, due to increase in competition and flow of new drugs, the company had to dispose the business and pay all its liabilities and dues.

Presently the company has its own cash resource, with this the company is proposing to diversify and to take over sick company which has excellent future potential. The company is in advance negotiation to some other company and soon rehab to acquire business in power and chemicals.

The board of directors of the company has been exploring new business opportunities since manufacturing operations becoming unviable were discontinued. The company has no secured loans and has surplus funds which can be leveraged to commence any new business.

The registered office of the company is located at 5, Kumud Apartment CHS, Karnik Road, Chikan Ghar, Kalyan, Thane District, Pin Code - 421301, Maharashtra.

 

Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback